Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Post Quarterly Financial Results conference call with investors / analyst
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding financial results for the quarter and half year ended 30th September 2025. It states that the transcript has been placed on the company's website and is notifying the exchange accordingly. The document itself does not contain the transcript but is an announcement of its availability. The document length is short (1502 characters), and it serves as a notification rather than the full transcript. According to the classification rules, a full transcript of a conference call is classified as Call Transcript (CT). However, since this document only announces the transcript's availability and does not contain the transcript itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other categories. Therefore, the classification is RNS with high confidence.
2025-11-13 English
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2025
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the audio recording of a conference call with analysts and investors about the financial results for the quarter and half year ended 30th September 2025. It references a previous letter and provides a link to the audio recording on the company's website. The document does not contain the transcript itself, nor detailed financial data or analysis. It is an announcement about the availability of the conference call recording, not the transcript or the financial report. Given the short length (1475 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than a full Call Transcript (CT) or Interim Report (IR).
2025-11-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a previous letter and providing a link to the audio recording of a conference call with analysts and investors regarding financial results for the quarter and half year ended 30th September 2025. The document does not contain the transcript itself but announces the availability of the audio recording on the company's website. The document length is short (1475 characters), and it serves as an announcement rather than the full transcript. According to the classification rules, a document announcing or linking to a conference call recording without the full transcript should be classified as a Regulatory Filing (RNS) because it does not contain the full call transcript text. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2025-11-07 English
Partial Redemption of Commercial Papers issued under ISIN INE685A07124
Capital/Financing Update Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the partial redemption of Non-Convertible Debentures (NCDs) by the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities) rather than a full financial report or earnings release. The document length is short (1303 characters), and it is a direct announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-11-07 English
Press Release
Interim / Quarterly Report Classification · 90% confidence The document is a full set of audited standalone financial results for the quarter and half year ended 30 September 2025, including an Independent Auditor’s Report and detailed financial statements (revenues, expenses, P&L line items). It is not merely a short press release or announcement that the report is attached; it contains substantive interim financial data and an auditor’s opinion. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-11-07 English
Investor Presentation on financial results Q2 FY 2025-26
Investor Presentation Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, dated November 7, 2025, enclosing a presentation to analysts on unaudited consolidated financial results for the quarter and half year ended September 30, 2025. The content includes revenue summaries for Q2 and H1 FY 2025-26, indicating it is a presentation of financial results rather than the full report itself. The document length is short (2041 characters), and it explicitly states it is a presentation to analysts. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not an earnings release (ER) because it contains more detailed data and is presented as a presentation, not just key highlights. It is not an Interim/Quarterly Report (IR) because it does not contain full financial statements or substantive financial data and analysis, only summary tables and a presentation format. Therefore, the correct classification is Investor Presentation (IP).
2025-11-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.